Please check your internet connection and try again.
# Miconazole Vaginal Pessary
## Overview
Miconazole is an imidazole antifungal agent. The vaginal pessary formulation is designed for localized treatment of vaginal yeast infections.
## Primary Indications
Treatment of vulvovaginal candidiasis (yeast infection).
## Adult Dosing
* **100 mg pessary:** Insert one pessary vaginally at bedtime for 7 consecutive nights.
* **200 mg pessary:** Insert one pessary vaginally at bedtime for 3 consecutive nights.
* **Advantage of longer duration therapy (7-day) over shorter duration (3-day) may be slightly higher cure rates, particularly in patients with more severe symptoms.**
## Pediatric Dosing
* Data specifically for miconazole vaginal pessaries in pediatric populations are limited.
* Use in pediatric patients should be guided by a healthcare provider, and alternative formulations or treatment durations may be considered.
## Dose Adjustments
* No dose adjustment is necessary for renal or hepatic impairment as systemic absorption is minimal.
## Contraindications
* Hypersensitivity to miconazole or any component of the formulation.
## Adverse Effects
* **Common:** Vaginal burning, itching, irritation. Pelvic cramps may occur.
* **Less Common:** Rash, hives.
## Key Drug Interactions
* **CYP3A4 Inhibitor:** Miconazole is a potent inhibitor of CYP3A4. Coadministration with miconazole (especially systemic forms, but caution with vaginal forms if significant absorption occurs) can increase the plasma concentrations of drugs metabolized by CYP3A4, potentially leading to serious or life-threatening toxicity. Examples include:
* Certain statins (e.g., simvastatin, atorvastatin)
* Certain opioids (e.g., fentanyl)
* Certain benzodiazepines (e.g., midazolam, triazolam)
* Certain calcium channel blockers (e.g., nifedipine, amlodipine)
* **Advise patients to report any new medications or concerning symptoms while using miconazole.**
## Monitoring
* Clinical signs and symptoms of vulvovaginal candidiasis.
* Patient reported adverse effects.
## Clinical Pearls
* Ensure complete insertion of the pessary for optimal efficacy.
* Advise patients to avoid sexual intercourse during treatment.
* Consider the use of sanitary pads to manage potential leakage.
* If symptoms do not improve after completing the course of therapy, patients should be advised to seek medical attention for re-evaluation.
* Pregnancy: While systemic absorption is low, the 3-day regimen is generally preferred in pregnancy, particularly during the first trimester, if treatment is deemed necessary. Consult prescribing information for specific guidance.
***
**Disclaimer:** This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always consult the most current prescribing information and your healthcare provider before making any treatment decisions.
